London Daily

Focus on the big picture.
Monday, Jul 21, 2025

Covid: Trust regulator on AstraZeneca vaccine safety, Boris Johnson says

Covid: Trust regulator on AstraZeneca vaccine safety, Boris Johnson says

People should get their Covid-19 jab when invited, the PM has said, amid concerns about potential side effects of the Oxford-AstraZeneca vaccine.

Boris Johnson said getting vaccinated was "the key thing" and the regulator's advice was to keep giving the jab.

It comes after a European Medicines Agency official, speaking in a personal capacity, said there appeared to be a link with the jab and rare blood clots.

More than 31.6 million people in the UK have had a first vaccine dose.

A total of 5.4 million people have received a second dose.

Two vaccines - developed by Oxford-AstraZeneca and Pfizer-BioNtech - are being used in the UK, while A third - from Moderna - has been approved.

The European Medicines Agency's (EMA) safety committee has been reviewing very rare cases of unusual blood clots in people vaccinated with the Oxford-AstraZeneca vaccine.

It said that the committee had "not yet reached a conclusion and the review is currently ongoing", but it is expected to announce findings on Wednesday or Thursday.

The UK regulator the Medicines and Healthcare Products Regulatory Agency (MHRA) says the benefits of the jab continue to outweigh any risk.

During a visit to the AstraZeneca manufacturing plant in Macclesfield, Cheshire, Mr Johnson defended its vaccine.

"On the Oxford-AstraZeneca vaccine, the best thing people should do is look at what the MHRA say, our independent regulator - that's why we have them, that's why they are independent," said Mr Johnson, who has received the first dose of the vaccine himself.

"Their advice to people is to keep going out there, get your jab, get your second jab."

The prime minister added: "The best thing of all is to vaccinate our population, get everybody out getting the jab, that's the key thing and that's what I would advocate, number one."


Speaking to an Italian newspaper in a personal capacity, Marco Cavaleri, head of vaccines at the EMA, is reported to have suggested a clear link between the jab and rare blood clots, though admitted there was uncertainty how the vaccine would cause the complication.

The EMA has previously said that there was "no evidence" to support restricting the use of the Oxford-AstraZeneca vaccine in any population.

Dr Rogerio Pinto de Sa Gaspar, director of regulation and prequalification at the World Health Organization, said there was "no link for the moment" between the Oxford-AstraZeneca vaccine and rare blood clots.

The MHRA is investigating reports of a very rare and specific type of blood clot in the brain, known as cerebral venous sinus thrombosis (CVST), occurring together with low levels of platelets (thrombocytopenia) following vaccination.

A number of countries have suspended the use of the jab among younger people, including in Germany, which has paused it for people aged below 60, and Canada, where the jab is not being given to those under 55.

In total, the UK has secured 457 million Covid vaccine doses, of which 100 million are from AstraZeneca. Vaccines from Moderna will be deployed in the UK "around the third week of April", Vaccines Minister Nadhim Zahawi has said.


The MHRA has said it identified 30 cases of rare blood clot events out of 18.1 million doses of the jab administered up to and including 24 March. There have been seven deaths among the 30 cases.

But the regulator's chief executive Dr June Raine said: "People should continue to get their vaccine when invited to do so.

"Our thorough and detailed review is ongoing into reports of very rare and specific types of blood clots with low platelets [the cells involved in clotting] following the Covid-19 vaccine AstraZeneca.

"No decision has yet been made on any regulatory action."

Prof Adam Finn, a member of the Joint Committee on Vaccination and Immunisation (JCVI), which advises the UK government, told the BBC there was "a lot of uncertainties around" and more information was "desperately" needed.

But, he said, there were some "clear certainties around" including the facts that both of the vaccines used in the UK were "highly effective against Covid" while the risk of getting sick or dying with Covid for those who are currently being offered doses, "are far and away greater than any small theoretical risk that may exist relating to these cases".

There have been a further 2,379 coronavirus cases in the UK and another 20 deaths within 28 days of a positive Covid test, according to the latest government figures.


The PM on the safety of the AstraZeneca jab


Newsletter

Related Articles

0:00
0:00
Close
Man Dies After Being Pulled Into MRI Machine Due to Metal Chain in New York Clinic
NVIDIA Achieves $4 Trillion Valuation Amid AI Demand
US Revokes Visas of Brazilian Corrupted Judges Amid Fake Bolsonaro Investigation
U.S. Congress Approves Rescissions Act Cutting Federal Funding for NPR and PBS
North Korea Restricts Foreign Tourist Access to New Seaside Resort
Brazil's Supreme Court Imposes Radical Restrictions on Former President Bolsonaro
Centrist Criticism of von der Leyen Resurfaces as she Survives EU Confidence Vote
Judge Criticizes DOJ Over Secrecy in Dropping Charges Against Gang Leader
Apple Closes $16.5 Billion Tax Dispute With Ireland
Von der Leyen Faces Setback Over €2 Trillion EU Budget Proposal
UK and Germany Collaborate on Global Military Equipment Sales
Trump Plans Over 10% Tariffs on African and Caribbean Nations
Flying Taxi CEO Reclaims Billionaire Status After Stock Surge
Epstein Files Deepen Republican Party Divide
Zuckerberg Faces $8 Billion Privacy Lawsuit From Meta Shareholders
FIFA Pressured to Rethink World Cup Calendar Due to Climate Change
SpaceX Nears $400 Billion Valuation With New Share Sale
Microsoft, US Lab to Use AI for Faster Nuclear Plant Licensing
Trump Walks Back Talk of Firing Fed Chair Jerome Powell
Zelensky Reshuffles Cabinet to Win Support at Home and in Washington
"Can You Hit Moscow?" Trump Asked Zelensky To Make Putin "Feel The Pain"
Irish Tech Worker Detained 100 days by US Authorities for Overstaying Visa
Dimon Warns on Fed Independence as Trump Administration Eyes Powell’s Succession
Church of England Removes 1991 Sexuality Guidelines from Clergy Selection
Superman Franchise Achieves Success with Latest Release
Hungary's Viktor Orban Rejects Agreements on Illegal Migration
Jeff Bezos Considers Purchasing Condé Nast as a Wedding Gift
Ghislaine Maxwell Says She’s Ready to Testify Before Congress on Epstein’s Criminal Empire
Bal des Pompiers: A Celebration of Community and Firefighter Culture in France
FBI Chief Kash Patel Denies Resignation Speculations Amid Epstein List Controversy
Air India Pilot’s Mental Health Records Under Scrutiny
Google Secures Windsurf AI Coding Team in $2.4 Billion Licence Deal
Jamie Dimon Warns Europe Is Losing Global Competitiveness and Flags Market Complacency
South African Police Minister Suspended Amid Organised Crime Allegations
Nvidia CEO Claims Chinese Military Reluctance to Use US AI Technology
Hong Kong Advances Digital Asset Strategy to Address Economic Challenges
Australia Rules Out Pre‑commitment of Troops, Reinforces Defence Posture Amid US‑China Tensions
Martha Wells Says Humanity Still Far from True Artificial Intelligence
Nvidia Becomes World’s First Four‑Trillion‑Dollar Company Amid AI Boom
U.S. Resumes Deportations to Third Countries After Supreme Court Ruling
Excavation Begins at Site of Mass Grave for Children at Former Irish Institution
Iranian President Reportedly Injured During Israeli Strike on Secret Facility
EU Delays Retaliatory Tariffs Amid New U.S. Threats on Imports
Trump Defends Attorney General Pam Bondi Amid Epstein Memo Backlash
Renault Shares Drop as CEO Luca de Meo Announces Departure Amid Reports of Move to Kering
Senior Aides for King Charles and Prince Harry Hold Secret Peace Summit
Anti‑Semitism ‘Normalised’ in Middle‑Class Britain, Says Commission Co‑Chair
King Charles Meets David Beckham at Chelsea Flower Show
If the Department is Really About Justice: Ghislaine Maxwell Should Be Freed Now
NYC Candidate Zohran Mamdani’s ‘Antifada’ Remarks Spark National Debate on Political Language and Economic Policy
×